Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria

Adriana Rakowska, Monika Slowinska, Elzbieta Kowalska-Oledzka, Malgorzata Olszewska, Lidia Rudnicka, Adriana Rakowska, Monika Slowinska, Elzbieta Kowalska-Oledzka, Malgorzata Olszewska, Lidia Rudnicka

Abstract

Objective: Establishing the trichoscopy criteria of female androgenic alopecia (FAGA).

Design: Trichoscopy images were retrospectively evaluated.

Setting: Dermatologic hospital-based clinic and private practice offices.

Patients and methods: One hundred and thirty-one females (59 with androgenic alopecia, 33 with chronic telogen effluvium (CTE), 39 healthy controls). The diagnosis was based on clinical examination and confirmed by histopatology.

Main outcome measure: Trichoscopy results obtained in frontal, occipital and both temporal areas of the scalp under a 20-fold and 70-fold magnification, including average hair thickness, number of 'yellow dots' and vellus hairs, number of hairs in one pilosebaceous unit and percentage of follicular ostia with perifollicullar hyperpigmentation.

Results: Average hair thickness in frontal area versus occiput was, respectively, 0.061 ± 0.008 mm versus 0.058 ± 0.007 mm in healthy controls, 0.047 ± 0.007 mm versus 0.052 ± 0.008 mm in androgenic alopecia and 0.056 ± 0.007 mm versus 0.053 ± 0.009 mm in CTE. Mean percentage of thin hairs (< 0.03 mm) in androgenic alopecia was 20.9 ± 12% and was significantly higher than in healthy controls (6.15 ± 4.6%, P < 0.001) or in CTE (10.4 ± 3.9%, P < 0.001). The number of yellow dots, pilosebaceous units with only one hair and with perifollicular hyperpigmentation was significantly increased in androgenic alopecia. Classification and Regression Tree Analysis was performed to establish diagnostic criteria for FAGA.

Conclusion: FAGA may be differentiated from CTE based on trichoscopy criteria. Major criteria are ratio of (1) more than four yellow dots in four images (70-fold magnification) in the frontal area, (2) lower average hair thickness in the frontal area compared to the occiput and (3) more than 10% of thin hairs (below 0.03 mm) in the frontal area. Minor criteria encompass increased frontal to occipital ratio of (1) single-hair pilosebaceous units, (2) vellus hairs and (3) perifollicular discoloration. Fulfillment of two major criteria or one major and two minor criteria allows to diagnose FAGA based on trichoscopy with a 98% specificity.

Keywords: Alopecia; dermoscopy; hair; trichoscopy; videodermoscopy.

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Mean hair diameter in frontal, occipital and left temporal areas of patients with female androgenic alopecia (FAGA), chronic telogen effluvium (CTE) and healthy controls. Asterix indicates the most important, statistically significant differences between them (P

Figure 2

Percentage of thin, medium-sized and…

Figure 2

Percentage of thin, medium-sized and thick hairs in frontal and occipital areas in…

Figure 2
Percentage of thin, medium-sized and thick hairs in frontal and occipital areas in healthy controls, patients with female androgenic alopecia (FAGA) and chronic telogen effluvium (CTE). Asterix marks statistically significant differences (P

Figure 3

Trichoscopy of frontal scalp area…

Figure 3

Trichoscopy of frontal scalp area in androgenic alopecia (a and b) and chronic…

Figure 3
Trichoscopy of frontal scalp area in androgenic alopecia (a and b) and chronic telogen effluvium (c and d). Images presented in 70-fold (a and c) and 20-fold magnification (b and d). Red arrows: Vellus hairs; green arrows: Short, new anagen hairs; red asterix: Yellow dots

Figure 4

Percentage distribution of pilosebaceous units…

Figure 4

Percentage distribution of pilosebaceous units with one, two and three hairs. In chronic…

Figure 4
Percentage distribution of pilosebaceous units with one, two and three hairs. In chronic telogen effluvium patients as well as in the healthy controls, the distribution was similar. Thus, only healthy control results and patients with androgenic alopecia are presented

Figure 5

Yellow dots in frontal, occipital…

Figure 5

Yellow dots in frontal, occipital and left temporal areas of all three groups…

Figure 5
Yellow dots in frontal, occipital and left temporal areas of all three groups of patients, presented as a number counted in four field of visions at 70-fold magnifications. Asterix marks statistically significant differences (P < 0.001)
Similar articles
References
    1. van Neste D. Female patients complaining about hair loss: Documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram. Skin Res Technol. 2006;12:83–8. - PubMed
    1. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopses in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol. 2004;51:189–99. - PubMed
    1. Whiting D. Chronic telogen effluvium. Dermatol Clin. 1996;14:697–11. - PubMed
    1. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2003;27:389–5. - PubMed
    1. Sinclair R. Chronic telogen effluvium or early androgenic alopecia? Int J Dermatol. 2004;43:842–3. - PubMed
Show all 26 references
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 2
Figure 2
Percentage of thin, medium-sized and thick hairs in frontal and occipital areas in healthy controls, patients with female androgenic alopecia (FAGA) and chronic telogen effluvium (CTE). Asterix marks statistically significant differences (P

Figure 3

Trichoscopy of frontal scalp area…

Figure 3

Trichoscopy of frontal scalp area in androgenic alopecia (a and b) and chronic…

Figure 3
Trichoscopy of frontal scalp area in androgenic alopecia (a and b) and chronic telogen effluvium (c and d). Images presented in 70-fold (a and c) and 20-fold magnification (b and d). Red arrows: Vellus hairs; green arrows: Short, new anagen hairs; red asterix: Yellow dots

Figure 4

Percentage distribution of pilosebaceous units…

Figure 4

Percentage distribution of pilosebaceous units with one, two and three hairs. In chronic…

Figure 4
Percentage distribution of pilosebaceous units with one, two and three hairs. In chronic telogen effluvium patients as well as in the healthy controls, the distribution was similar. Thus, only healthy control results and patients with androgenic alopecia are presented

Figure 5

Yellow dots in frontal, occipital…

Figure 5

Yellow dots in frontal, occipital and left temporal areas of all three groups…

Figure 5
Yellow dots in frontal, occipital and left temporal areas of all three groups of patients, presented as a number counted in four field of visions at 70-fold magnifications. Asterix marks statistically significant differences (P < 0.001)
Figure 3
Figure 3
Trichoscopy of frontal scalp area in androgenic alopecia (a and b) and chronic telogen effluvium (c and d). Images presented in 70-fold (a and c) and 20-fold magnification (b and d). Red arrows: Vellus hairs; green arrows: Short, new anagen hairs; red asterix: Yellow dots
Figure 4
Figure 4
Percentage distribution of pilosebaceous units with one, two and three hairs. In chronic telogen effluvium patients as well as in the healthy controls, the distribution was similar. Thus, only healthy control results and patients with androgenic alopecia are presented
Figure 5
Figure 5
Yellow dots in frontal, occipital and left temporal areas of all three groups of patients, presented as a number counted in four field of visions at 70-fold magnifications. Asterix marks statistically significant differences (P < 0.001)

References

    1. van Neste D. Female patients complaining about hair loss: Documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram. Skin Res Technol. 2006;12:83–8.
    1. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopses in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol. 2004;51:189–99.
    1. Whiting D. Chronic telogen effluvium. Dermatol Clin. 1996;14:697–11.
    1. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2003;27:389–5.
    1. Sinclair R. Chronic telogen effluvium or early androgenic alopecia? Int J Dermatol. 2004;43:842–3.
    1. Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45:S70–80.
    1. Price VH. Androgenic alopecia in women. J Investig Dermatol Symp Proc. 2003;8:24–7.
    1. van Neste D. Assessment of hair loss: Clinical relevance of hair growth evaluation methods. Clin Exp Dermatol. 2002;27:358–65.
    1. Olszewska M, Rudnicka L, Rakowska A, Kowalska-Oledzka E, Slowinska M. Trichoscopy. Arch Dermatol. 2008;144:1007.
    1. Rudnicka L, Olszewska M, Majsterek M. Presence and future of dermoscopy. Expert Rev Dermatol. 2006;1:769–72.
    1. Lacarrubba F, Dall`Oglio F, Rita Nasca M, Micali G. Videodermatoscopy enhances diagnostic capability in some forms of hair loss. Am J Clin Dermatol. 2004;5:205–8.
    1. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. 2006;55:799–806.
    1. Slowinska M, Rudnicka L, Schwartz RA, Kowalska-Oledzka E, Rakowska A, Sicinska J, et al. Comma hairs: A dermoscopic marker for tinea capitis: A rapid diagnostic method. J Am Acad Dermatol. 2008;59:S77–9.
    1. Olszewska M, Rudnicka L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol. 2005;4:637–40.
    1. Inui S, Nakajima T, Itami S. Dry dermoscopy in clinical treatment of alopecia areata. J Dermatol. 2007;34:635–9.
    1. Tosti A, Whiting D, Iorizzo M, Pazzaglia M, Misciali C, Vincenzi C, et al. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol. 2008;59:64–7.
    1. Piraccini B BM, Voudouris S, Pazzaglia M, Rech G, Vicenzi C, Tosti A. Lipedematous alopecia of the scalp. Dermatol Online J. 2006;12:6.
    1. Di Stefani A, Hofmann-Wellenhof R, Zalaudek I. Dermoscopy for diagnosis and treatment monitoring of pediculosis capitis. J Am Acad Dermatol. 2006;54:909–11.
    1. Rakowska A, Slowinska M, Kowalska-Oledzka E. Trichoscopy in genetic hair shaft abnormalities. J Dermatol Case Rep. 2008;2:14–20.
    1. Rakowska A, Slowinska M, Czuwara J, Olszewska M, Rudnicka L. Dermoscopy as a tool for rapid diagnosis of monilethrix. J Drugs Dermatol. 2007;6:222–4.
    1. Riedel-Baiama B, Riedel A. Female pattern hair loss may be triggered by low oestrogen to androgen ratio. Endocr Regul. 2008;42:13–6.
    1. Shapiro J. Clinical practice: Hair loss in women. N Engl J Med. 2007;357:1620–30.
    1. Leroy T, van Neste D. Contrast enhanced phototrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenic alopecia. Skin Res Technol. 2002;8:106–11.
    1. Ekmekci RTY, Koslu A. Phototrichogram findings in women with androgenic alopecia. Skin Res Technol. 2006;12:309–12.
    1. Eudy G, Solomon AR. The histopathology of noncicatricial alopecia. Semin Cutan Med Surg. 2006;25:35–40.
    1. Deloche C C, de Lacharriere O, Misciali C, Piraccini BM, Vincenzi C, Bastien P, et al. Histological features of peripilar signs associated with androgenic alopecia. Arch Dermatol Res. 2004;295:422–8.

Source: PubMed

3
Iratkozz fel